Prokidney (PROK) Net Income towards Common Stockholders (2021 - 2026)

Prokidney (PROK) has 6 years of Net Income towards Common Stockholders data on file, last reported at -$42.6 million in Q1 2026.

• Net Income towards Common Stockholders for Q1 2026 came in at -$42.6 million, down 12.3% year-over-year; the trailing twelve-month figure through Mar 2026 was -$156.3 million (up 5.83% YoY), and the FY2025 annual result was -$69.0 million, down 12.75% from the prior year.
• Net Income towards Common Stockholders fell to -$42.6 million in Q1 2026 per PROK's latest filing, from -$40.9 million in the prior quarter.
• Over five years, Net Income towards Common Stockholders peaked at -$14.4 million in Q4 2022 and troughed at -$67.5 million in Q1 2022.
• A 5-year average of -$37.1 million and a median of -$37.0 million in 2025 frame the typical range for Net Income towards Common Stockholders.
• The sharpest annual moves came in 2022 and 2023: Net Income towards Common Stockholders tumbled 1302215.71% in 2022, then soared 45.31% in 2023.
• A 5-year view of Net Income towards Common Stockholders shows it stood at -$14.4 million in 2022, then tumbled by 50.86% to -$21.7 million in 2023, then sank by 123.18% to -$48.5 million in 2024, then rose by 15.74% to -$40.9 million in 2025, then declined by 4.33% to -$42.6 million in 2026.
• Business Quant data shows PROK's Net Income towards Common Stockholders at -$42.6 million in Q1 2026, -$40.9 million in Q4 2025, and -$35.8 million in Q3 2025.